Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$372.5K
25.30K shares
LORRAIN DANIEL S. plans to sell 25.30K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $372.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 4.17K | ||
Completed
Units to sell
4.17K
Market value
$56.0K
Units to sell
4.17K
Market value
$62.6K
Units to sell
3.82K
Market value
$61.2K
Units to sell
4.30K
Market value
$68.9K
Units to sell
100.00
Market value
$1.6K
Units to sell
400.00
Market value
$6.4K
Units to sell
4.17K
Market value
$62.3K
Planned — Approximate Date
Units to sell
4.17K
Market value
$53.5K
Units
25.30K
Value
$372.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/6/2026 | 4.17K | $56.0K | — | Completed |
3/2/2026 | 4.17K | $62.6K | — | Completed |
2/25/2026 | 3.82K | $61.2K | — | Completed |
2/24/2026 | 4.30K | $68.9K | — | Completed |
2/19/2026 | 100.00 | $1.6K | — | Completed |
2/11/2026 | 400.00 | $6.4K | — | Completed |
2/3/2026 | 4.17K | $62.3K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 4.17K | $53.5K | NASDAQ | Planned |
| Total | 25.30K | $372.5K | ||